Home GPCR & G Protein -Neuronal Signaling -Endocrinology & Hormones CCK receptor

CCK receptor

Isoform-selective Products

CCK receptor Products

  • All (3)
  • CCK receptor Inhibitor (1)
  • CCK receptor Antagonist (1)
  • CCK receptor Agonist (1)
  • New CCK receptor Products
Catalog No. Product Name Information Product Use Citations Product Validations
S2032 Rebamipide Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
Signal Transduct Target Ther, 2021, 6(1):148
University of Alberta, 2014, Yahya Muhammad Fiteih
S9690 Caerulein (FI-6934) Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.
J Adv Res, 2025, S2090-1232(25)00225-5
S6939 Nastorazepide Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S2032 Rebamipide Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
Signal Transduct Target Ther, 2021, 6(1):148
University of Alberta, 2014, Yahya Muhammad Fiteih
S6939 Nastorazepide Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S9690 Caerulein (FI-6934) Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.
J Adv Res, 2025, S2090-1232(25)00225-5

Choose Selective CCK receptor Inhibitors

Tags: CCK receptor inhibitor|CCK receptor agonist|CCK receptor activator|CCK receptor inducer|CCK receptor antagonist|CCK receptor signaling pathway|CCK receptor assay kit